OVERVIEW

Advanced Strategies to Improve CVD Outcomes in Patients with Chronic Coronary Artery Disease and Peripheral Artery Disease is organized by the AcademicCME.

Program Dates: December 28, 2019 - December 27, 2020

Accreditation:
Credit Designation Statements:
• Purdue University College of Pharmacy designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• Purdue University Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This program has been approved for 1.5 contact hours.

Program Overview:
This CME/CE program, derived from content presented at the 2019 American Heart Association Scientific Sessions in Philadelphia, Pennsylvania, will highlight advanced strategies for improving cardiovascular disease (CVD) outcomes in patients with chronic coronary artery disease (CAD) and peripheral artery disease (PAD). The expert faculty, chaired by Dr. Christopher P. Cannon, will first provide an introduction and state of the science of CAD and PAD, and transition into a review of the role of anticoagulants in preventive cardiology. Recent clinical trial data, particularly that of anticoagulants and aspirin combination therapeutic strategies, will be reviewed as it relates to clinical decision making for healthcare professionals. Finally, the interactive panel will cover the role of the interprofessional team in providing optimal, tailored treatment plans to improve CVD outcomes and quality of life for patients with CAD and PAD.

Learning Objectives
• Recognize the role of anticoagulants in preventive cardiology in CAD/PAD
• Analyze the most current data for anticoagulants + aspirin combination therapeutic strategies for the treatment of CV events in CAD/PAD
• Develop collaborative treatment strategies to prevent cardiovascular events in patients with CAD/PAD

Additional details will be posted as soon as information is available.